Zhuang Shougang, Schnellmann Rick G
Department of Pharmaceutical Sciences, Medical University of South Carolina, 280 Calhoun Street, Charleston, SC 29425, USA.
J Pharmacol Exp Ther. 2005 Jul;314(1):383-90. doi: 10.1124/jpet.104.080648. Epub 2005 Apr 15.
Primary cultures of renal proximal tubules are known to recapitulate several early events in the process of renal regeneration following injury. In this study, we show that suramin, a polysulfonated naphthylurea, stimulates outgrowth, scattering, and proliferation of primary cultures of renal proximal tubule cells (RPTC). These responses were comparable to those produced by epidermal growth factor (EGF). However, AG-1478 [4-(3'-chloroanilino)-6,7-dimethoxy-quinazoline], a specific inhibitor of the EGF receptor, blocked EGF but not suramin-induced RPTC outgrowth, scattering, and proliferation. Suramin stimulated phosphorylation of Akt, a downstream kinase of phosphoinositide 3-kinase (PI3K), extracellular signaling-regulated kinase 1/2 (ERK1/2), and Src, but not the EGF receptor. Blockade of Src, but not the EGF receptor, inhibited Akt and ERK1/2 phosphorylation. Furthermore, inactivation of PI3K with LY294002 [2-(4morpholinyl)-8-phenyl-4H-1-benzopyran-4-one] blocked suramin-induced RPTC outgrowth, scattering, and proliferation, whereas blockade of ERK1/2 had no effect. These data identify novel effects of suramin in RPTC outgrowth, scattering, and proliferation. Furthermore, suramin-induced outgrowth, scattering, and proliferation of RPTC are through Src-mediated activation of the PI3K pathway but not ERK1/2 or the EGF receptor.
已知肾近端小管的原代培养可重现损伤后肾脏再生过程中的几个早期事件。在本研究中,我们发现苏拉明(一种多磺酸萘脲)可刺激肾近端小管细胞(RPTC)原代培养物的生长、分散和增殖。这些反应与表皮生长因子(EGF)所产生的反应相当。然而,EGF受体的特异性抑制剂AG-1478 [4-(3'-氯苯胺基)-6,7-二甲氧基喹唑啉]可阻断EGF诱导的RPTC生长、分散和增殖,但不能阻断苏拉明诱导的这些反应。苏拉明可刺激磷酸肌醇3激酶(PI3K)的下游激酶Akt、细胞外信号调节激酶1/2(ERK1/2)和Src的磷酸化,但不能刺激EGF受体的磷酸化。阻断Src而非EGF受体可抑制Akt和ERK1/2的磷酸化。此外,用LY294002 [2-(4-吗啉基)-8-苯基-4H-1-苯并吡喃-4-酮]使PI3K失活可阻断苏拉明诱导的RPTC生长、分散和增殖,而阻断ERK1/2则无作用。这些数据确定了苏拉明在RPTC生长、分散和增殖方面的新作用。此外,苏拉明诱导的RPTC生长、分散和增殖是通过Src介导的PI3K途径激活实现的,而非ERK1/2或EGF受体。